Pharmaceutical-grade cannabis extracts.
Aureum’s manufacturing facility is currently under construction and will be purpose built to ensure industry best-practice and compliance with the requirements of GMP (Good Manufacturing Practice). This will allow Aureum to work with its established cultivation partners in producing the purest quality pharmaceutical-grade cannabis extracts.
Aureum will offer a complete outsourcing solution from pre-processing of raw material to primary and secondary packaging of products. Our goal is to bring quality to life, and we will do this by always delivering on our promise of consistent quality assured.
Peter is co-founder and CEO of Aureum and has been involved in the Danish medicinal cannabis industry from the beginning. Peter has professional experience in finance and accounting with global shipping company A.P. Moller Maersk, at both group level and in the tanker industry. Peter started working in business development within the medical cannabis industry at Medican, which later led to the establishment of Aureum.
Inge-Lise Rønnow is a high-performance pharmacists with extensive hands-on experience in the pharmaceutical industry. Inge-Lise has been responsible for tablet production and GMP compliance as Production Manager at Takeda Nycomed. After having been stationed in China for 5 years, Inge-Lise returned to Denmark as Senior Consultant and delegate QP for AlfaNordic. Since medicinal cannabis was legalized in Denmark, Inge-Lise have worked closely with some of the largest LP’s advising on implementation and GMP compliance.
Henriette Dahlgaard has 20+ years of
experience from the pharmaceutical industry
hereof 18 years in Quality Assurance and 4
years in validation. Henriette has a proven
track record in building Quality Management
Systems, establishing and executing validation
masterplans to hosting and performing
inspections. Henriette have a broad
experience in each stage of a product lifecycle,
a wide range of product types and
manufacturing on a global scale. Latest
Henriette has worked as Director of R&D and
Regions Quality at LEO Pharma QA, Alfa
Nordic and Canopy Growth Denmark.